Skip to main content
. 2016 Sep 15;7(45):73638–73650. doi: 10.18632/oncotarget.12039

Table 2. Association of high IDH1-R132H expression with clinicopathological characteristics in gastric cancer patients.

Characteristic n IDH1-R132H IDH1-R132H+ Pearson χ2 p
Total 412
Gender 0.1381 0.710
 Male 302 190(62.91) 112(37.09)
 Female 110 67(60.91) 43(39.09)
Age 0.2391 0.625
 <60 147 94(63.95) 53(36.05)
 ≥60 265 163(61.51) 102(38.49)
Histological type 8.8793 0.064
 Tubular 354 217(61.30) 137(38.70)
 Mixed (Tubular and mucinous) 12 7(58.33) 5(41.67)
 Mucinous 21 14(66.67) 7(33.33)
 Signet ring cell 15 14(93.33) 1(6.67)
 Othersa 10 5(50.00) 5(50.00)
Differentiation 3.4498 0.178
 Well 11 4(40.00) 7(60.00)
 Middle 115 68(58.97) 47(41.03)
 Poor 227 144(65.04) 83(34.96)
 Othersb 58 40 18
TNM stage 13.1516 0.041*
 0+Ia 24 12(50.00) 12(50.00)
 Ib 49 25(51.02) 24(48.98)
 IIa 96 52(54.17) 44(45.83)
 IIb 59 37(62.71) 22(37.29)
 IIIa 75 53(70.67) 22(29.33)
 IIIb 69 49(71.01) 20(28.99)
 IIIc+IV 40 29(72.50) 11(27.50)
T 2.1390 0.544
 Tis+ T1 35 18(51.43) 17(48.57)
 T2 91 56(61.54) 35(38.46)
 T3 252 161(63.89) 91(36.11)
 T4 34 22(64.71) 12(35.29)
N 12.4282 0.006*
 N0 176 79(51.63) 74(48.37)
 N1 81 53(66.25) 27(33.75)
 N2 93 56(68.29) 26(31.71)
 N3 92 69(71.13) 28(28.87)
M 1.3387 0.247
 M0 383 236(61.62) 147(38.38)
 M1 29 21(72.41) 8(27.59)
Preoperative CEA, ng/m1 1.3118 0.252
 ≦5 156 104(66.67) 52(33.33)
 > 5 60 35(58.33) 25(41.67)
 Unknown 196 118 78
Preoperative CA199, U/ml 0.5120 0.474
 ≦37 156 113(64.20) 63(35.80)
 > 37 60 24(70.59) 10(29.41)
 Unknown 202 120 82
*

P<0.05;

a

others: papillary adenocarcinoma, 3 cases; adeno-squamous carcinoma, 3 cases; squamous cell carcinoma, 2 cases; neuroendocrine carcinoma,1 case; carcinoid,1 case;

b

others: besides tubular.